Search Results 1721-1730 of 16371 for Chronic Lymphocytic Leukemia

1. A Study to Compare the Effectiveness and Safety of bb2121 Versus Standard Regimens in Subjects with Relapsed and Refractory Multiple Myeloma (RRMM) - Mayo Clinic

   Subject has documented diagnosis ... Subject has active or history of plasma cell leukemia, Waldenstrom's macroglobulinemia, POEMS syndrome or amyloidosis.

2. A Study of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Gastroenteritis - Mayo Clinic

   Diagnosis of celiac disease or active H. pylori ... Grade 2 or higher lymphopenia (< 0.8 × 109/L lymphocytes). ... Diagnosis of Hypereosinophilic ...

3. Clinomics Program - Center for Individualized Medicine - Mayo Clinic Research

   Genome sequencing provides a diagnosis for a rare neurological disorder. Genetic Testing's Impact on Patient Care — Paige's Story. Whole-exome sequencing probes ...

4. Ruxolitinib Phosphate (Oral JAK Inhibitor INCB18424) in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell or Peripheral T-Cell Non-Hodgkin Lymphoma - Mayo Clinic

   Subjects must have histologically documented relapsed or refractory disease, with a diagnosis of one of the following lymphoid malignancies: Diffuse Large B- ...

5. A Long Term Study of Molecular and Structural Imaging in Atypical Alzheimer's Disease - Mayo Clinic

   The purpose of this study is to learn more about amyloid and tau burden in the brain of patients with Atypical Alzheimer's Disease and how that burden may ...

6. Safety and Efficacy of ALLO-605 an Anti-BCMA Allogeneic CAR T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma - Mayo Clinic

   Phase 4 trials look at long-term ... - Documented diagnosis of relapsed/refractory multiple myeloma (MM) - ... leptomeningeal involvement of myeloma or plasma cell ...

7. Efficacy and Safety Study of bb2121 in Subjects With Relapsed and Refractory Multiple Myeloma (KarMMa) - Mayo Clinic

   Documented diagnosis of multiple myeloma: ... Subjects with active or history of plasma cell leukemia ... chronic, therapeutic dosing of anti-coagulants ...

8. Laryngeal (Voice Box) Cancer Clinical Trials - Mayo Clinic Research

   ... severe laryngeal or laryngotracheal incompetence. A Study to Optimize ... lymphatic drainage (MLD) versus use of a pneumatic compression device (PCD) ...

9. A Study of the Safety and Drug/Body Interactions of LAM-002A for Patients with Non-Hodgkin's Lymphoma - Mayo Clinic

   Confirmed diagnosis of B-cell Non-Hodgkin's lymphoma limited to follicular lymphoma, DLBCL, mantle cell lymphoma, marginal zone lymphoma, or CLL/SLL that ...

10. Long-term Observational Extension of CREST-2 - Mayo Clinic

    CREST-2 is a multicenter randomized trial of intensive medical management (IMM) with or without revascularization in patients with asymptomatic high-grade ...